CDKN2B-AS1 and hepatocellular carcinoma: Additionally, ANRIL positively influences cell proliferation through the miR-181a-5p/CCNG1, miR-203a/CDK2, miR-141-3p/CCND1/2, and miR-497/CDK6 axes in GC, HCC, RC, and HNSCC, respectively [96,146,225,226].